As of March 1, 2024, CSI Compressco is forecasting capital expenditures for the fiscal year to fall within the range...

Mammoth Energy Services (NASDAQ:TUSK) announced their quarterly financial results on March 1, 2024, revealing a loss of $(0.12) per share....

On March 1, 2024, analyst Douglas Tsao from HC Wainwright & Co. reiterated a Buy rating on argenx (NASDAQ: ARGX)...

Cullinan Oncology has just received the green light from the FDA for its groundbreaking Investigational New Drug Application for the...

Analysts' Take on Kimberly-Clark Stock as of March 1, 2024 Analysts have recently shared their evaluations of Kimberly-Clark (NYSE: KMB),...

Analyst Ratings on Definitive Healthcare _____________________________________________________________________________________ Analysts have been sharing their views on Definitive Healthcare (NASDAQ:DH) in recent months, with...

Amneal Pharmaceuticals has just released its financial results for the fourth quarter and full year of 2023, showcasing a variety...

Sweetgreen's Strong Performance in Q4 2023 ___________________________________________________ On February 29, 2024, Sweetgreen (NYSE: SG) released its fourth-quarter 2023 financial results,...

Organogenesis Holdings Inc. recently released its financial results for the fourth quarter of 2023, revealing a decrease in net revenue...

Elastic Corporation's latest financial report for Q3 has resulted in a surprising drop in its stock value, despite surpassing expectations....